FASN and fatty liver disease: The latter mechanism is consistent with the inhibition of hepatic steatosis in ob/ob mice with deleted Rho-kinases through the repression of Fasn and Scd1 (stearoyl desaturase-1) without an influence on FA β-oxidation.